COVID-19: human immune response and the influence of food ingredients and active compounds
The human immune system is the first line of defense in the prevention of viruses and
diseases, and several immune response mechanisms are engaged at the onset of a …
diseases, and several immune response mechanisms are engaged at the onset of a …
[HTML][HTML] Focus: health equity: an overview of health disparities in asthma
MF Perez, MT Coutinho - The Yale journal of biology and medicine, 2021 - ncbi.nlm.nih.gov
Asthma is a heterogeneous disease characterized by inflammation in the respiratory airways
which manifests clinically with wheezing, cough, and episodic periods of chest tightness; if …
which manifests clinically with wheezing, cough, and episodic periods of chest tightness; if …
[图书][B] Superior: The return of race science
A Saini - 2019 - books.google.com
2019 Best-Of Lists: 10 Best Science Books of the Year (Smithsonian Magazine)· Best
Science Books of the Year (NPR's Science Friday)· Best Science and Technology Books …
Science Books of the Year (NPR's Science Friday)· Best Science and Technology Books …
Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label
R De Vries, YWF Dagelet, P Spoor… - European …, 2018 - Eur Respiratory Soc
Asthma and chronic obstructive pulmonary disease (COPD) are complex and overlapping
diseases that include inflammatory phenotypes. Novel anti-eosinophilic/anti-neutrophilic …
diseases that include inflammatory phenotypes. Novel anti-eosinophilic/anti-neutrophilic …
Impact of historic migrations and evolutionary processes on human immunity
J Domínguez-Andrés, MG Netea - Trends in Immunology, 2019 - cell.com
The evolution of mankind has constantly been influenced by the pathogens encountered.
The various populations of modern humans that ventured out of Africa adapted to different …
The various populations of modern humans that ventured out of Africa adapted to different …
Questions in mild asthma: an official American Thoracic Society research statement
A Mohan, NL Lugogo, NA Hanania… - American journal of …, 2023 - atsjournals.org
Background: Patients with mild asthma are believed to represent the majority of patients with
asthma. Disease-associated risks such as exacerbations, lung function decline, and death …
asthma. Disease-associated risks such as exacerbations, lung function decline, and death …
A randomized, placebo‐controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER)
CD Austin, M Gonzalez Edick… - Clinical & …, 2020 - Wiley Online Library
Background The anti‐interleukin 13 (IL‐13) monoclonal antibody lebrikizumab improves
lung function in patients with moderate‐to‐severe uncontrolled asthma, but its effects on …
lung function in patients with moderate‐to‐severe uncontrolled asthma, but its effects on …
Disentangling the coronavirus disease 2019 health disparities in African Americans: Biological, environmental, and social factors
The stark racial disparities related to the coronavirus disease 2019 (COVID-19) pandemic in
the United States, wherein minority populations are disproportionately getting infected and …
the United States, wherein minority populations are disproportionately getting infected and …
Advances in asthma in 2017: Mechanisms, biologics, and genetics
MH Grayson, S Feldman, BT Prince, PJ Patel… - Journal of Allergy and …, 2018 - Elsevier
This review summarizes some of the most significant advances in asthma research over the
past year. We first focus on novel discoveries in the mechanism of asthma development and …
past year. We first focus on novel discoveries in the mechanism of asthma development and …
[HTML][HTML] Step-up therapy in black children and adults with poorly controlled asthma
Background Morbidity from asthma is disproportionately higher among black patients than
among white patients, and black patients constitute the minority of participants in trials …
among white patients, and black patients constitute the minority of participants in trials …